The markets opened mixed with the Dow slipping 8 points to 11,138 as investors monitor developments from the Group of 20 meeting of finance ministers and central bank governors. Nasdaq rose 9 points to 2469.
On the upside
General Electric's (NYSE: GE) GE Healthcare will pay approximately $580 million to acquire cancer diagnostic firm Clarient (Nasdaq: CLRT).
KeyCorp (NYSE: KEY) reversed year ago losses to post a profit for the third quarter that surpassed analyst estimates by a wide margin.
Second quarter earnings slipped for Compuware (Nasdaq: CPWR) but the results beat analyst expectations.
On the downside
The Food and Drug Administration refused to approve ViroPharma's (Nasdaq: VPHM) request to begin manufacturing industrial scale lots of its Cinryze (C1 Esterase Inhibitor [Human]) until additional information is submitted for review.
Align Technology (Nasdaq: ALGN) reversed year ago losses but the maker of Invisalign forecast fourth quarter results below estimates.
RAIT Financial Trust (NYSE: RAS) swung to a profit but revenue dropped.
In the broad market, advancing issues outpaced decliners by a margin of 7 to 5 on the NYSE and by more than 5 to 4 on Nasdaq. The Russell 2000 which tracks small cap stocks added 2 points to 700.
